VACBF
Nykode Therapeutics AS

6
Mkt Cap
$798.08M
Volume
320.00
52W High
$0.5191
52W Low
$0.165
PE Ratio
-5.62
VACBF Fundamentals
Price
$0.294
Prev Close
$0.2725
Open
$0.294
50D MA
$0.209
Beta
0.00
Avg. Volume
476.19
EPS (Annual)
-$0.1189
P/B
0.93
Rev/Employee
$62,438.85
Loading...
Loading...
Nykode Therapeutics ASA is a clinical-stage biopharmaceutical company which engages in discovering and developing of novel immunotherapies. It focuses on developing field of individualized cancer neoantigen vaccines by using the Vaccibody technology to generate therapeutics to treat cancer. The company was founded by Inger Sandlie and Agnete Brunsvik Fredriksen on November 22, 2006 and is headquartered in Oslo, Norway.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
139

Frequently Asked Questions

What is Market Cap of Nykode Therapeutics AS?
What is the 52-week high for Nykode Therapeutics AS?
What is the 52-week low for Nykode Therapeutics AS?
What is Nykode Therapeutics AS stock price today?
What was Nykode Therapeutics AS stock price yesterday?
What is the PE ratio of Nykode Therapeutics AS?
What is the Price-to-Book ratio of Nykode Therapeutics AS?
What is the 50-day moving average of Nykode Therapeutics AS?
How many employess does Nykode Therapeutics AS has?

Latest VACBF News

View
No VACBF news at the moment.

Advertisement|Remove ads.

Advertisement|Remove ads.